Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Efficacy and safety of onasemnogene abeparvovec for the treatment of patients with spinal muscular atrophy type 1: A systematic review with meta-analysis

Table 2

Profile of certainty of evidence in the treatment with onasemnogene abeparvovec in patients of up to 2 years of age diagnosed with SMA type 1.

Table 2

doi: https://doi.org/10.1371/journal.pone.0302860.t002